UB Paderborn / Katalog / Suche / in CDI

Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain

Journal of Pharmacological Sciences, 2010, Vol.114(1), pp.119-122

2010

Volltextzugriff (PDF)

Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia

Experimental neurology, 2006-05, Vol.199 (1), p.92-102

2006

Volltextzugriff (PDF)

Tacrolimus (FK506) Limits Accumulation of Granulocytes and Platelets and Protects against Brain Damage after Transient Focal Cerebral Ischemia in Rat

Biological and Pharmaceutical Bulletin, 2007, Vol.30(2), pp.313-317

2007

Volltextzugriff (PDF)

Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats

Brain research, 2004-07, Vol.1014 (1), p.120-130

2004

Volltextzugriff (PDF)

Tacrolimus, a Potential Neuroprotective Agent, Ameliorates Ischemic Brain Damage and Neurologic Deficits After Focal Cerebral Ischemia in Nonhuman Primates

Journal of cerebral blood flow and metabolism, 2003-10, Vol.23 (10), p.1183-1194

2003

Volltextzugriff (PDF)

Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist

Journal of neurotrauma, 2005-11, Vol.22 (11), p.1362-1373

2005

Volltextzugriff (PDF)

Temporal and topographic profiles of tissue hypoxia following transient focal cerebral ischemia in rats

Journal of Veterinary Medical Science, 2006, Vol.68(8), pp.803-807

2006

Volltextzugriff (PDF)

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model

Brain research, 2009-02, Vol.1254, p.99-108

2009

Volltextzugriff (PDF)

Translational PK–PD modeling in pain

Journal of pharmacokinetics and pharmacodynamics, 2013-06, Vol.40 (3), p.401-418

2013

Volltextzugriff (PDF)

P3-58 AS1069562, (+)-isomer of indeloxazine, but not duloxetine has curative-like analgesic effect in rat model of streptozotocin-induced diabetic neuropathy

Journal of Pharmacological Sciences, 2013-03, Vol.121 (suppl), p.226-226

2013

Volltextzugriff (PDF)

Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: Comparison with tissue plasminogen activator

Experimental neurology, 2007-03, Vol.204 (1), p.138-146

2007

Volltextzugriff (PDF)

P3-59 AS1069562, (+)-isomer of indeloxazine, is an unique SNRI with a broader analgesic effects: Comparison with duloxetine and amitriptyline

Journal of Pharmacological Sciences, 2013-03, Vol.121 (suppl), p.226-226

2013

Volltextzugriff (PDF)

Growth of NiWO4 crystals from a Na2W2O7 flux

Journal of materials science, 1996, Vol.31 (20), p.5309-5312

1996

Volltextzugriff (PDF)

Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy

Brain research, 2003-03, Vol.965 (1), p.137-145

2003

Volltextzugriff (PDF)

Sustained Analgesic Effect of the Rho Kinase Inhibitor AS18928O2 in Rat Models of Chronic Pain

Journal of Pharmacological Sciences, 2010, Vol.114 (1), p.119-122

2010

Volltextzugriff (PDF)

Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models

Brain research, 2007-05, Vol.1149, p.181-190

2007

Volltextzugriff (PDF)

A Combined Treatment With Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

Journal of cerebral blood flow and metabolism, 2002-10, Vol.22 (10), p.1205-1211

2002

Volltextzugriff (PDF)

Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia: Stem/progenitor cell biology & stroke/hypoxic-ischemic cerebral injury

Experimental neurology, 2006, Vol.199 (1), p.92-102

2006

Volltextzugriff (PDF)

P3K-78 FK506 reduces hemorrhagic transformation produced by delayed t-PA treatment in the thrombotic focal cerebral ischemia in spontaneously hypertensive rats

Journal of Pharmacological Sciences, 2006, Vol.100 (suppl.2), p.258-258

2006

Volltextzugriff (PDF)

1C1330 FK506 (tacrolimus) ameliorates the ischemic brain damage and neurological deficits in a non-human primate stroke model

Journal of Pharmacological Sciences, 2003, Vol.91 (suppl.1), p.73-73

2003

Volltextzugriff (PDF)

A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: Increased neuroprotective efficacy and extended therapeutic time window

Journal of cerebral blood flow and metabolism, 2002-10, Vol.22 (10), p.1205-1211

2002

Volltextzugriff (PDF)

Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats

Stroke (1970), 1994-03, Vol.25 (3), p.677-682

1994

Volltextzugriff (PDF)

The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats

The Japanese Journal of Pharmacology, 1992, Vol.58(4), pp.457-460

1992

Volltextzugriff (PDF)

Effects of nilvadipine on neuronal function in the ischemic cat brain

Surgical neurology, 1992-04, Vol.37 (4), p.255-260

1992

Volltextzugriff (PDF)

The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats

Japanese Journal of Pharmacology, 1992-01, Vol.58 (4), p.457-460

1992

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain

Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia

Tacrolimus (FK506) Limits Accumulation of Granulocytes and Platelets and Protects against Brain Damage after Transient Focal Cerebral Ischemia in Rat

Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats

Tacrolimus, a Potential Neuroprotective Agent, Ameliorates Ischemic Brain Damage and Neurologic Deficits After Focal Cerebral Ischemia in Nonhuman Primates

Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist

Temporal and topographic profiles of tissue hypoxia following transient focal cerebral ischemia in rats

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model

Translational PK–PD modeling in pain

P3-58 AS1069562, (+)-isomer of indeloxazine, but not duloxetine has curative-like analgesic effect in rat model of streptozotocin-induced diabetic neuropathy

Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: Comparison with tissue plasminogen activator

P3-59 AS1069562, (+)-isomer of indeloxazine, is an unique SNRI with a broader analgesic effects: Comparison with duloxetine and amitriptyline

Growth of NiWO4 crystals from a Na2W2O7 flux

Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy

Sustained Analgesic Effect of the Rho Kinase Inhibitor AS18928O2 in Rat Models of Chronic Pain

Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models

A Combined Treatment With Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia: Stem/progenitor cell biology & stroke/hypoxic-ischemic cerebral injury

P3K-78 FK506 reduces hemorrhagic transformation produced by delayed t-PA treatment in the thrombotic focal cerebral ischemia in spontaneously hypertensive rats

1C1330 FK506 (tacrolimus) ameliorates the ischemic brain damage and neurological deficits in a non-human primate stroke model

A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: Increased neuroprotective efficacy and extended therapeutic time window

Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats

The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats

Effects of nilvadipine on neuronal function in the ischemic cat brain

The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats

Suchergebnisse filtern